© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

You are one of 7.5 million annual visitors to OpenSecrets. If you each donated just $1 a year, we'd never worry about funding again.

The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug ...

The European Commission's Antitrust unit cleared Friday the acquisition of US-based pharmaceutical company Cephalon Inc. (CEPH) by the generic pharmaceutical company Teva Pharmaceuticals ...